Acetylsalicylic acid Not Yet Recruiting Phase N/A Trials for Peripheral Artery Disease(PAD) / Coronary Artery Disease (CAD)

IndicationsStatusPurposePhase
Not Yet RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT04298567Study to Learn More About the Effectiveness and Safety of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Patients Suffering From a Condition That Affects the Blood Vessels Supplying the Heart (CAD) and/or a Condition That Affects the Blood Vessel of the Lower Limbs (PAD).